NTS071 is an oral small molecule allosteric reactivator targeting p53 Y220C with a novel scaffold. It selectively binds to ...

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET ...

However, these stocks also carry high risk, as their performance is heavily reliant on innovation, clinical trial success, ...

Myriad Genetics MYGN underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish ...

each with different drug targets for indications with central nervous system (CNS) involvement. The AACR Annual Meeting is being held from April 25-30, 2025, in Chicago, IL. “The data we are ...

SHANGHAI, April 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in ...